{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:59:30Z","timestamp":1785862770322,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08731-9","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:13:59Z","timestamp":1785341639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemotherapy-driven gut microbiota remodeling in ovarian cancer: a prospective longitudinal study"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenpei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruomeng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"8731_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"8731_CR2","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","volume":"334","author":"G Caruso","year":"2025","unstructured":"Caruso G, Weroha SJ, Cliby W. Ovarian cancer: a review. JAMA. 2025;334(14):1278\u201391. https:\/\/doi.org\/10.1001\/jama.2025.9495.","journal-title":"JAMA"},{"key":"8731_CR3","doi-asserted-by":"publisher","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m 3773. https:\/\/doi.org\/10.1136\/bmj.m3773.","DOI":"10.1136\/bmj.m3773"},{"issue":"11","key":"8731_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41571-022-00685-3","volume":"19","author":"NM Kuderer","year":"2022","unstructured":"Kuderer NM, Desai A, Lustberg MB, Lyman GH. Mitigating acute chemotherapy-associated adverse events in patients with cancer. Nat Rev Clin Oncol. 2022;19(11):681\u201397. https:\/\/doi.org\/10.1038\/s41571-022-00685-3.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"8731_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24(8):577\u201395. https:\/\/doi.org\/10.1038\/s41577-024-01014-8.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8731_CR6","doi-asserted-by":"publisher","first-page":"2477816","DOI":"10.1080\/19490976.2025.2477816","volume":"17","author":"RE Steinert","year":"2025","unstructured":"Steinert RE, Rehman A, Sadabad MS, Milanese A, Wittwer-Schegg J, Burton JP, et al. Microbial micronutrient sharing, gut redox balance and keystone taxa as a basis for a new perspective to solutions targeting health from the gut. Gut Microbes. 2025;17(1):2477816. https:\/\/doi.org\/10.1080\/19490976.2025.2477816.","journal-title":"Gut Microbes"},{"key":"8731_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jare.2023.11.027","volume":"64","author":"S Li","year":"2024","unstructured":"Li S, Zhu S, Yu J. The role of gut microbiota and metabolites in cancer chemotherapy. J Adv Res. 2024;64:223\u201335. https:\/\/doi.org\/10.1016\/j.jare.2023.11.027.","journal-title":"J Adv Res"},{"key":"8731_CR8","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.drup.2020.100742","volume":"54","author":"L Mosca","year":"2021","unstructured":"Mosca L, Ilari A, Fazi F, Assaraf YG. Colotti G: taxanes in cancer treatment: activity, chemoresistance and its overcoming. Drug Resist Updat. 2021;54:100742.","journal-title":"Drug Resist Updat"},{"key":"8731_CR9","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fonc.2025.1690541","volume":"15","author":"B Zhang","year":"2025","unstructured":"Zhang B, Mohd Sahardi NFN, Chew KT, Di W, Shafiee MN. Gut microbiome alterations and their clinical and biological implications in ovarian cancer: a systematic review. Front Oncol. 2025;15:2025. https:\/\/doi.org\/10.3389\/fonc.2025.1690541.","journal-title":"Front Oncol"},{"issue":"1","key":"8731_CR10","doi-asserted-by":"publisher","first-page":"16504","DOI":"10.1038\/s41598-025-99912-x","volume":"15","author":"W Gong","year":"2025","unstructured":"Gong W, Jin G, Bao Y, Liu Q, Ni M, Wang J, et al. Characteristics and potential diagnostic value of gut microbiota in ovarian tumor patients. Sci Rep-UK. 2025;15(1):16504. https:\/\/doi.org\/10.1038\/s41598-025-99912-x.","journal-title":"Sci Rep-UK"},{"key":"8731_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12967-025-06339-z","volume":"23","author":"C Chen","year":"2025","unstructured":"Chen C, Deng C, Li Y, He S, Liu Y, Pan S, et al. Machine learning-derived diagnostic model of epithelial ovarian cancer based on gut microbiome signatures. J Transl Med. 2025;23:319. https:\/\/doi.org\/10.1186\/s12967-025-06339-z.","journal-title":"J Transl Med"},{"key":"8731_CR12","doi-asserted-by":"publisher","first-page":"1440742","DOI":"10.3389\/fcimb.2024.1440742","volume":"14","author":"M Zhang","year":"2024","unstructured":"Zhang M, Mo J, Huang W, Bao Y, Luo X, Yuan L. The ovarian cancer-associated microbiome contributes to the tumor\u2019s inflammatory microenvironment. Front Cell Infect Microbiol. 2024;14:1440742. https:\/\/doi.org\/10.3389\/fcimb.2024.1440742.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"8731_CR13","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.1038\/s41467-024-54565-8","volume":"15","author":"SR Rosario","year":"2024","unstructured":"Rosario SR, Long MD, Chilakapati S, Gomez EC, Battaglia S, Singh PK, et al. Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer. Nat Commun. 2024;15(1):10609. https:\/\/doi.org\/10.1038\/s41467-024-54565-8.","journal-title":"Nat Commun"},{"issue":"4","key":"8731_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25042237","volume":"25","author":"G Cocomazzi","year":"2024","unstructured":"Cocomazzi G, Del Pup L, Contu V, Maggio G, Parmegiani L, Ciampaglia W, et al. Gynecological cancers and microbiota dynamics: insights into pathogenesis and therapy. Int J Mol Sci. 2024;25(4):25. https:\/\/doi.org\/10.3390\/ijms25042237.","journal-title":"Int J Mol Sci"},{"key":"8731_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12885-025-13652-9","volume":"25","author":"W Shi","year":"2025","unstructured":"Shi W, Zhang Y, Cheng S, Zhao Y, Li N, Li Y, et al. Protocol of the SOCFC project: a longitudinal cohort study of ovarian cancer patients, high-risk populations, and healthy controls to identify factors and biomarkers associated with disease diagnosis and prognosis. BMC Cancer. 2025;25:355. https:\/\/doi.org\/10.1186\/s12885-025-13652-9.","journal-title":"BMC Cancer"},{"issue":"6","key":"8731_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. NAT Biotechnol. 2020;38(6):685\u201388. https:\/\/doi.org\/10.1038\/s41587-020-0548-6.","journal-title":"NAT Biotechnol"},{"issue":"24","key":"8731_CR17","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1158\/0008-5472.CAN-22-0455","volume":"82","author":"LM Chambers","year":"2022","unstructured":"Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, Tewari S, Trestan L, et al. Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer. Cancer Res. 2022;82(24):4654\u201369. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0455.","journal-title":"Cancer Res"},{"issue":"1","key":"8731_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41698-025-01034-0","volume":"9","author":"D B\u00f6hm","year":"2025","unstructured":"B\u00f6hm D, Russ E, Guchelaar HJ, Ziemons J, Penders J, Smidt ML, et al. The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review. NPJ Precis Oncol. 2025;9(1):265. https:\/\/doi.org\/10.1038\/s41698-025-01034-0.","journal-title":"NPJ Precis Oncol"},{"key":"8731_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbi.2024.05.039","volume":"120","author":"LD Otto-Dobos","year":"2024","unstructured":"Otto-Dobos LD, Grant CV, Lahoud AA, Wilcox OR, Strehle LD, Loman BR, et al. Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain Behav Immun. 2024;120:208\u201320. https:\/\/doi.org\/10.1016\/j.bbi.2024.05.039.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"8731_CR20","doi-asserted-by":"publisher","first-page":"2393270","DOI":"10.1080\/19490976.2024.2393270","volume":"16","author":"KE Hays","year":"2024","unstructured":"Hays KE, Pfaffinger JM, Ryznar R. The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. Gut Microbes. 2024;16(1):2393270. https:\/\/doi.org\/10.1080\/19490976.2024.2393270.","journal-title":"Gut Microbes"},{"issue":"7","key":"8731_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436\u201350. https:\/\/doi.org\/10.1038\/s41580-019-0123-5.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"8731_CR22","doi-asserted-by":"publisher","first-page":"115358","DOI":"10.1016\/j.celrep.2025.115358","volume":"44","author":"P P\u00e9rez Escriva","year":"2025","unstructured":"P\u00e9rez Escriva P, Correia Tavares Bernardino C, Letellier E, P\u00e9rez Escriva P. De-coding the complex role of microbial metabolites in cancer. Cell Rep. 2025;44(3):115358. https:\/\/doi.org\/10.1016\/j.celrep.2025.115358.","journal-title":"Cell Rep"},{"key":"8731_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","volume":"155","author":"HI Akbarali","year":"2022","unstructured":"Akbarali HI, Muchhala KH, Jessup DK, Cheatham S. Chemotherapy induced gastrointestinal toxicities. Adv Cancer Res. 2022;155:131\u201366.","journal-title":"Adv Cancer Res"},{"issue":"4","key":"8731_CR24","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.apsb.2023.12.015","volume":"14","author":"D Bai","year":"2024","unstructured":"Bai D, Zhao J, Wang R, Du J, Zhou C, Gu C, et al. Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier. Acta Pharm Sin B. 2024;14(4):1677\u201392. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.015.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"8731_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.immuni.2019.08.020","volume":"51","author":"K Troha","year":"2019","unstructured":"Troha K, Nagy P, Pivovar A, Lazzaro BP, Hartley PS, Buchon N. Nephrocytes remove microbiota-derived peptidoglycan from systemic circulation to maintain immune homeostasis. IMMUNITY. 2019;51(4):625\u201337.e3. https:\/\/doi.org\/10.1016\/j.immuni.2019.08.020.","journal-title":"IMMUNITY"},{"issue":"8","key":"8731_CR26","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/gutjnl-2024-332891","volume":"74","author":"M Hu","year":"2025","unstructured":"Hu M, Xu Y, Wang Y, Huang Z, Wang L, Zeng F, et al. Gut microbial-derived N-acetylmuramic acid alleviates colorectal cancer via the AKT1 pathway. Gut. 2025;74(8):1230\u201345. https:\/\/doi.org\/10.1136\/gutjnl-2024-332891.","journal-title":"Gut"},{"issue":"1","key":"8731_CR27","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1038\/s41467-020-19940-1","volume":"11","author":"L Tian","year":"2020","unstructured":"Tian L, Wang X-W, Wu A-K, Fan Y, Friedman J, Dahlin A, et al. Deciphering functional redundancy in the human microbiome. Nat Commun. 2020;11(1):6217. https:\/\/doi.org\/10.1038\/s41467-020-19940-1.","journal-title":"Nat Commun"},{"issue":"6","key":"8731_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017;14(6):356\u201365. https:\/\/doi.org\/10.1038\/nrgastro.2017.20.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"8731_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41575-025-01100-9","volume":"22","author":"A Caminero","year":"2025","unstructured":"Caminero A, Tropini C, Valles-Colomer M, Shung DL, Gibbons SM, Surette MG, Sokol H, Tomeo NJ, Alenghat T, Awoniyi M, et al. Credible inferences in microbiome research: ensuring rigour, reproducibility and relevance in the era of AI. Nat Rev Gastro Hepat. 2025;22(11):788\u2013803. https:\/\/doi.org\/10.1038\/s41575-025-01100-9.","journal-title":"Nat Rev Gastro Hepat"},{"issue":"3","key":"8731_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41592-025-02923-9","volume":"23","author":"WA Nickols","year":"2026","unstructured":"Nickols WA, Kuntz T, Shen J, Maharjan S, Mallick H, Franzosa EA, et al. MaAsLin 3: refining and extending generalized multivariable linear models for meta-omic association discovery. Nat Methods. 2026;23(3):554\u201364. https:\/\/doi.org\/10.1038\/s41592-025-02923-9.","journal-title":"Nat Methods"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08731-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08731-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:58:33Z","timestamp":1785859113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08731-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8731"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08731-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki, and the protocol was reviewed and approved by the Scientific and Ethical Committee of the Shanghai First Maternity and Infant Hospital affiliated with Tongji University (Approval No. KS23167). Written informed consent to participate was obtained from all individual patients included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"991"}}